1. Home
  2. PSEC vs NNNN Comparison

PSEC vs NNNN Comparison

Compare PSEC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prospect Capital Corporation

PSEC

Prospect Capital Corporation

HOLD

Current Price

$2.50

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$26.65

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSEC
NNNN
Founded
2004
2021
Country
United States
Germany
Employees
8
27
Industry
Finance/Investors Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSEC
NNNN
Price
$2.50
$26.65
Analyst Decision
Sell
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
4.6M
12.8K
Earning Date
05-08-2026
04-07-2026
Dividend Yield
20.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$7.03
52 Week High
$3.77
$55.65

Technical Indicators

Market Signals
Indicator
PSEC
NNNN
Relative Strength Index (RSI) 35.04 47.85
Support Level N/A $26.31
Resistance Level $2.86 $30.21
Average True Range (ATR) 0.08 2.10
MACD -0.02 -0.30
Stochastic Oscillator 10.26 15.58

Price Performance

Historical Comparison
PSEC
NNNN

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: